COST-UTILITY ANALYSIS OF FENOFIBRATE IN SLOWING PROGRESSION OF DIABETIC RETINOPATHY IN VIETNAM. YHCĐ. 2026;67(CĐ11-NCKH). doi:10.52163/yhc.v67iCD11.6071